Carol A O'Donnell insider trades
Open-market stock purchases and sales by Carol A O'Donnell, Director at Apimeds Pharmaceuticals US, Inc, from SEC Form 4 filings since Nov 15, 2018.
Open-market stock purchases and sales by Carol A O'Donnell, Director at Apimeds Pharmaceuticals US, Inc, from SEC Form 4 filings since Nov 15, 2018.